Putu K Duff1,2,3, Deborah M Money2,4, Gina S Ogilvie2,3,5, Florence Ranville1, Mary Kestler1,2,3, Melissa C Braschel1, Neora Pick2,3, Kate Shannon1,2,5. 1. Gender and Sexual Health Initiative, British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital, Vancouver, British Columbia, Canada. 2. Faculty of Medicine, University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada. 3. BC Women's Hospital, Vancouver, British Columbia, Canada. 4. Department of Obstetrics & Gynecology, University of British Columbia, Vancouver, British Columbia, Canada. 5. School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
OBJECTIVES: Although more women living with HIV (WLWH) are entering midlife, the experiences of perimenopausal and menopausal WLWH, including the effects of menopausal symptoms severity, remain understudied. This study longitudinally investigated the correlates of antiretroviral therapy (ART) adherence among perimenopausal and menopausal WLWH from Metro Vancouver. METHODS: Analyses drew on longitudinal data (2014-2017) from Sexual health and HIV/AIDS: Women's Longitudinal Needs Assessment, an ongoing community-based cohort of WLWH, aged 14+, from Metro Vancouver, Canada. At baseline and biannually, participants completed an interviewer-administered questionnaire. Bivariate and multivariable logistic regression with generalized estimating equations were used to identify the correlates of self-reported <95% ART adherence. RESULTS: The sample included 109 perimenopausal and menopausal WLWH (233 observations), with a median age of 49 years (IQR 44-53). Whereas most (68.8%) participants experienced menopausal symptoms, only 17% had received treatment (eg, antidepressants, hormone therapy) at baseline. In multivariable analysis, severe menopausal symptoms (adjusted odds ratio [AOR] 1.03, 95% confidence interval [CI] 1.00-1.06), injection drug use (AOR 2.86, 95% CI 1.44-5.55), and physical/sexual violence (AOR 2.33, 95% CI 1.02-5.26) independently and positively correlated with <95% adherence. CONCLUSIONS: These findings suggest that menopausal symptoms may undermine ART adherence, with overlapping vulnerabilities such as injection drug use and sexual/physical violence further exacerbating poor ART adherence. Women-centred, trauma-informed care approaches to detect menopause and treat menopausal symptoms are urgently needed. Such approaches should holistically address the intersecting barriers to adherence and link WLWH to peripheral health and social services, including trauma counseling and evidence-based harm reduction services.
OBJECTIVES: Although more women living with HIV (WLWH) are entering midlife, the experiences of perimenopausal and menopausal WLWH, including the effects of menopausal symptoms severity, remain understudied. This study longitudinally investigated the correlates of antiretroviral therapy (ART) adherence among perimenopausal and menopausal WLWH from Metro Vancouver. METHODS: Analyses drew on longitudinal data (2014-2017) from Sexual health and HIV/AIDS: Women's Longitudinal Needs Assessment, an ongoing community-based cohort of WLWH, aged 14+, from Metro Vancouver, Canada. At baseline and biannually, participants completed an interviewer-administered questionnaire. Bivariate and multivariable logistic regression with generalized estimating equations were used to identify the correlates of self-reported <95% ART adherence. RESULTS: The sample included 109 perimenopausal and menopausal WLWH (233 observations), with a median age of 49 years (IQR 44-53). Whereas most (68.8%) participants experienced menopausal symptoms, only 17% had received treatment (eg, antidepressants, hormone therapy) at baseline. In multivariable analysis, severe menopausal symptoms (adjusted odds ratio [AOR] 1.03, 95% confidence interval [CI] 1.00-1.06), injection drug use (AOR 2.86, 95% CI 1.44-5.55), and physical/sexual violence (AOR 2.33, 95% CI 1.02-5.26) independently and positively correlated with <95% adherence. CONCLUSIONS: These findings suggest that menopausal symptoms may undermine ART adherence, with overlapping vulnerabilities such as injection drug use and sexual/physical violence further exacerbating poor ART adherence. Women-centred, trauma-informed care approaches to detect menopause and treat menopausal symptoms are urgently needed. Such approaches should holistically address the intersecting barriers to adherence and link WLWH to peripheral health and social services, including trauma counseling and evidence-based harm reduction services.
Authors: Juan E Blümel; Peter Chedraui; German Baron; Emma Belzares; Ascanio Bencosme; Andres Calle; Luis Danckers; Maria T Espinoza; Daniel Flores; Gustavo Gomez; Jose A Hernandez-Bueno; Humberto Izaguirre; Patricia Leon-Leon; Selva Lima; Edward Mezones-Holguin; Alvaro Monterrosa; Desire Mostajo; Daysi Navarro; Eliana Ojeda; William Onatra; Monique Royer; Edwin Soto; Konstantinos Tserotas; Soledad Vallejo Journal: Menopause Date: 2011-07 Impact factor: 2.953
Authors: Pauline M Maki; Leah H Rubin; Mardge Cohen; Elizabeth T Golub; Ruth M Greenblatt; Mary Young; Rebecca M Schwartz; Kathryn Anastos; Judith A Cook Journal: Menopause Date: 2012-11 Impact factor: 2.953
Authors: M de Pommerol; M Hessamfar; S Lawson-Ayayi; D Neau; S Geffard; S Farbos; B Uwamaliya; M-A Vandenhende; J-L Pellegrin; S Blancpain; F Dabis; P Morlat Journal: Int J STD AIDS Date: 2011-02 Impact factor: 1.359
Authors: Jamila K Stockman; Meghan D Morris; Gustavo Martinez; Remedios Lozada; Thomas L Patterson; Monica D Ulibarri; Alicia Vera; Steffanie A Strathdee Journal: AIDS Behav Date: 2012-10
Authors: Evan Wood; Mark W Tyndall; Patricia M Spittal; Kathy Li; Aslam H Anis; Robert S Hogg; Julio S G Montaner; Michael V O'Shaughnessy; Martin T Schechter Journal: CMAJ Date: 2003-01-21 Impact factor: 8.262
Authors: Judith A Cook; Mardge H Cohen; Jane Burke; Dennis Grey; Kathryn Anastos; Lynn Kirstein; Herminia Palacio; Jean Richardson; Tracey Wilson; Mary Young Journal: J Acquir Immune Defic Syndr Date: 2002-08-01 Impact factor: 3.731
Authors: Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange Journal: PLoS One Date: 2013-12-18 Impact factor: 3.240
Authors: Putu Duff; Mary Kestler; Patience Chamboko; Melissa Braschel; Gina Ogilvie; Andrea Krüsi; Julio Montaner; Deborah Money; Kate Shannon Journal: AIDS Behav Date: 2018-09
Authors: Jennifer A Pellowski; Devon M Price; Abigail D Harrison; Emily L Tuthill; Landon Myer; Don Operario; Mark N Lurie Journal: AIDS Behav Date: 2019-08
Authors: Michael T Yin; Donald R Hoover; Qiuhu Shi; Phyllis C Tien; Mardge H Cohen; Seble Kassaye; Deborah Gustafson; Adaora Adimora; M Neale Weitzmann; Hector Bolivar; Amy Warriner; Sara H Bares; Anjali Sharma Journal: AIDS Date: 2022-06-22 Impact factor: 4.632
Authors: Putu Duff; Kate Shannon; Melissa Braschel; Flo Ranville; Mary Kestler; Ruth Elwood Martin; Andrea Krüsi; Kathleen Deering Journal: Int J STD AIDS Date: 2020-12-08 Impact factor: 1.359
Authors: Mabel Toribio; Evelynne S Fulda; Sarah M Chu; Zsofia D Drobni; Magid Awadalla; Madeline Cetlin; Takara L Stanley; Crystal M North; Michael D Nelson; Michael Jerosch-Herold; Lidia S Szczepaniak; Tricia H Burdo; Sara E Looby; Tomas G Neilan; Markella V Zanni Journal: Open Forum Infect Dis Date: 2021-01-12 Impact factor: 3.835
Authors: Danielle Solomon; Caroline A Sabin; Fiona Burns; Richard Gilson; Sris Allan; Annamiek de Ruiter; Rageshri Dhairyawan; Julie Fox; Yvonne Gilleece; Rachael Jones; Frank Post; Iain Reeves; Jonathan Ross; Andrew Ustianowski; Jane Shepherd; S Tariq Journal: AIDS Care Date: 2020-04-11
Authors: Olga Estefania Escobar Florez; Gabriela Aquilera; Jose Maria De la Roca-Chiapas; Maciste Habacuc Macías Cervantes; Ma Eugenia Garay-Sevilla Journal: Psychol Res Behav Manag Date: 2021-12-11
Authors: Anna Hachfeld; Andrew Atkinson; Petra Stute; Alexandra Calmy; Philip E Tarr; Katharine Darling; Baharak Babouee Flury; Christian Polli; Leila Sultan-Beyer; Irene A Abela; Karoline Aebi-Popp Journal: HIV Med Date: 2022-02-22 Impact factor: 3.094